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Allergenic foods represent a significant health risk for
persons who have an allergy to specific food. However,
this risk remains poorly characterised. Knowledge is
often missing on the different risk components such as
the presence of allergens in food, food consumption
behaviours of allergic sufferers and thresholds of reac-
tion. Usual risk assessment approaches cannot be easily
implemented to assess the risk from sporadic contami-
nation and that concerns only a small part of the popu-
lation. As a consequence, there is a lack of risk-based
guidance and operational tools of those involved in
allergen risk management, who are food industries, the
allergic individuals and the food regulators. To upgrade
knowledge, methodological and operational tools in
food allergy, MIRABEL involves various scientific fields
such as chemical analysis, dietary survey, medical
research, socio-economics, applied mathematics and sta-
tistics to exposure and risk assessments. In this way,
MIRABEL aims to set an integrated and operational fra-
mework for the allergic risk analysis, in order to
improve quality of life of allergic sufferers. Each risk
component will be investigated to accurately character-
ize the risk of food allergy and to test different risk
management options. To complete existing but sparse
information, field surveys will be conducted in order to
acquire accurate data on allergic consumers’ behaviours
relating to allergen-containing products and their
thresholds of reaction, and to allergen presence in food
consumed by allergic sufferers. In parallel, methodologi-
cal developments in Bayesian statistics and probabilistic
modelling will be realized to be able to combine the
acquired data in an integrated risk quantification model.
A cost-benefits analysis for the stakeholders (food indus-
try, allergic individuals and regulators) will also be con-
ducted to anticipate impacts of new policies. The
project will be focused on the peanut, which can be
adventitiously present in various foodstuffs such as cho-
colate, cereals or biscuits. This allergen is associated
with the highest prevalence of food allergy and is one of
the food allergens that lead to the most severe adverse
effects.
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